Cancer news source

• share
• favorite_border

LaShae Rolle, a Ph.D. candidate was just 26 when she was diagnosed with a rare type of breast cancer. She is now designing clinical trials and studies focused on underserved and marginalized minority communities – especially adolescents and young adults.

• share
• favorite_border

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.

• share
• favorite_border

The PdNHF has long been a trusted partner of Texas Tech Health El Paso, focused on leading, investing in, and supporting programs that promote health and prevent disease in our Borderplex region. The $5 million grant will be instrumental in elevating comprehensive cancer care by funding the recruitment of top-tier cancer specialists. This ensures the future center will be equipped to deliver expert care from its inception. Dr. Lange called it a foundational grant because it’s a cornerstone of the funding for the future Fox Cancer Center, emphasizing that through collective strength and action – the power of people – we can bring hope to members of our Borderplex community.

• share
• favorite_border

Hackensack Meridian Health’s Men’s Health Day Offers Screenings for Those at High Risk for Prostate Cancer & Other Diseases

• share
• favorite_border

UCLA's Dr. Roger Lo was awarded a $2 million grant from the National Institutes of Health to investigate innovative strategies to prevent drug resistance in melanoma treatment and improve the effectiveness of MAPK inhibitors, a common treatment for patients with melanomas that carry the BRAFV600 mutation.

• share
• favorite_border

Comprehensive gene panel testing, one of the exciting new tools in cancer diagnostics, warrants greater scrutiny — as does a federal program aimed at speeding up the review process for proposed new medical technologies. Those are conclusions of Yale medical experts who studied both and published a report in the Journal of the National Cancer Institute on Sept.

• share
• favorite_border

Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses. Their findings can support the design of an inhibitor that can target aggressive cancers.

• share
• favorite_border

The Cancer Research Institute and the Kidney Cancer Association are collaborating on a new kidney cancer immunotherapy research grant.

• share
• favorite_border

The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert is quoted explaining the results.

• share
• favorite_border

In a multisite randomized controlled trial published in JAMA Network Open in September 2024, the use of Ceevra 3D models in robotic prostatectomy procedures were shown to reduce risk of cancer recurrence, improve functional outcomes, and improve rates of trifecta outcomes.

• share
• favorite_border

If you ask Kate Lopez, RN, what her approach to caring for patients in the Cancer and Blood Disease Institute of Children’s Hospital Los Angeles is, she’ll tell you that the magic’s in the little things.  Those little things include gestures like ensuring patients have plenty of ice and water during chemo, adding comfort items to their rooms and, Lopez’s specialty: making them laugh.

• share
• favorite_border

Using newly released cancer surveillance data, researchers at the American Cancer Society (ACS) found decreases in cancer diagnoses and proportion of early-stage diagnoses continued in 2021 in the United States during the second year of the COVID-19 pandemic. The proportion of late-stage diagnoses was lower in 2021 than in 2020, but has not returned to pre-pandemic levels. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

Patients diagnosed with major diseases, including cancer, often experience financial hardship due to high out-of-pocket medical costs in the United States. However, little is known about changes in income, wealth, and debt before and after major disease diagnoses. New data by researchers at the American Cancer Society (ACS) shows these families face various new types of debts, especially medical debt, after diagnoses. Moreover, newly diagnosed with cancer is associated with an increased likelihood of experiencing medical debt. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

New research by scientists at the American Cancer Society (ACS) shows patients impacted by a wildfire disaster while recovering from lung cancer surgery have a longer in-hospital length of stay (LOS) than similar patients treated at the same facility at times when no disasters happened. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

New findings by researchers at the American Cancer Society (ACS) show total healthcare spending in the six months after a cancer diagnosis is considerable in the working-age population, with high out-of-pocket (OOP) costs for patients with private non-health maintenance organization (HMO) coverage. The study will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

A new study from researchers at the American Cancer Society (ACS) found that patients with stage 3 locally advanced non-small cell lung cancer (NSCLC) who received radiation treatment during a hurricane disaster were more likely to experience treatment completion delays. Researchers also reported that patients treated during a hurricane were more likely to receive higher total doses of radiation and complete more fractions. These findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

• share
• favorite_border

Claire Yun Kyoung Ryu Tiger, MD, PhD, medical oncologist in the Leukemia/Lymphoma/Hematologic Malignancies Program at Rutgers Cancer Institute and RWJBarnabas Health shares the basics about blood cancers.

• share
• favorite_border

The University of Kansas Cancer Center is part of the myeloMATCH trial, a large, coordinated effort to improve patient outcomes through targeted treatments for people with acute myeloid leukemia or myelodysplastic syndrome.